Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

Transcription-wide impact by RESCUE-induced off-target single-nucleotide variants in mammalian cells

ecRESCUE: a novel ecDHFR-regulated RESCUE system with reduced RNA off-targeting activity

Developing PspCas13b-based enhanced RESCUE system, eRESCUE, with efficient RNA base editing

Pan-cancer Investigation of C-to-U Editing Reveals Its Important Role in Cancer Development and New Targets for Cancer Treatment

Programmable RNA writing with trans-splicing

Scalable assessment of genome editing off-targets associated with genetic variants

Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editors

RES-Scanner: a Software Package for Genome-Wide Identification of RNA-editing Sites

SPRINT: an SNP-free Toolkit for Identifying RNA Editing Sites.

Harnessing RNA-based DNA repair pathways for targeted gene editing

An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification

REPAIRx, a specific yet highly efficient programmable A > I RNA base editor

Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Multimodal CRISPR screens uncover DDX39B as a global repressor of A-to-I RNA editing

RNA Base Editors: the Emerging Approach of RNA Therapeutics.

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

Programmable RNA base editing via targeted modifications

Human genetic diversity alters off-target outcomes of therapeutic gene editing

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA